Madrigal Pharmaceuticals
Madrigal Pharmaceuticals is seeking an Associate Director, Study Toxicologist to provide scientific oversight and execution support for nonclinical development programs focused on metabolic dysfunction-associated steatohepatitis (MASH). The role involves managing outsourced studies with contract research organizations (CROs) across toxicology, pharmacokinetics, and bioanalytical disciplines to ensure high-quality data for regulatory submissions. This position requires deep expertise in study design, vendor management, and data interpretation within a biopharmaceutical research environment.
Headquarters
Conshohocken, Pennsylvania, United States
Company Size
201-500 employees
Founded
2016
Delivering a Breakthrough Treatment Madrigal is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need. Left untreated, MASH can lead to progressive liver scarring, cirrhosis, liver failure, liver cancer, need for transplant and premature mortality. Our goal is to halt or reverse […]
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Madrigal Pharmaceuticals.
23% above the average for this role
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
2 weeks ago
Associate Director, Study Operations Manager - Nonclinical Toxicology
Centessa Pharmaceuticals
Associate Director, Nonclinical Development
ardelyx
Senior Toxicologist
Regeneron Pharmaceuticals
Toxicologist
BlueRidge Life Sciences
Project Toxicologist
argenx
Senior Toxicologist - Study Monitor
Eli Lilly and Company